Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,528Revenue $M0.0Net Margin (%)0Z-Score-7.3
Enterprise Value $M2,575EPS $-0.6Operating Margin %0F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %-18.8Quick Ratio0.7Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-26.5Current Ratio0.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-77.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M406ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with MNKD

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
MNKDJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$2.31 - $3.56
$ 6.23126%Sold Out0
MNKDJean-Marie Eveillard 2012-12-31 Buy 0.01%$1.85 - $2.83
$ 6.23188%New holding, 800000 sh.800,000
MNKDGeorge Soros 2007-09-30 Sold Out -0.01%$8.87 - $13.09
$ 6.23-39%Sold Out0
MNKDGeorge Soros 2007-06-30 Buy 0.01%$11.46 - $14.95
$ 6.23-53%New holding, 13493 sh.13,493
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MNKD is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

MNKD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Palumbo DianeVice President, Human Resource 2015-01-05Sell188,999$5.956.89view
Edstrom HakanPresident & COO 2014-12-01Sell74,668$5.897.98view
Palumbo DianeVice President, Human Resource 2014-12-01Sell183,522$5.897.98view
Martens JuergenCorporate VP 2014-11-24Sell140,000$6.143.58view
Thomson DavidVP & General Counsel 2014-11-24Sell118,114$6.143.58view
Martens JuergenCorporate VP 2014-10-31Sell63,800$6.094.43view
Martens JuergenCorporate VP 2014-10-03Sell63,800$5.4816.06view
Martens JuergenCorporate VP 2014-08-27Sell417$7.6-16.32view
Martens JuergenCorporate VP 2014-08-22Sell22,775$7.02-9.4view
Palumbo DianeVice President, Human Resource 2014-08-15Sell18,726$7.01-9.27view

Press Releases about MNKD :

    Quarterly/Annual Reports about MNKD:

    News about MNKD:

    Articles On GuruFocus.com
    Portfolio 1 Jan 03 2015 
    What to Watch for: November 3-7 Nov 04 2014 
    Roche to Acquire InterMune and Deliver Hope to Patients Worldwide Aug 25 2014 
    How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza Aug 15 2014 
    There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune Aug 14 2014 
    What This Upcoming Monday Means For MannKind Shareholders Aug 08 2014 
    Shareholders To Inhale Relief As MannKind Found Its Bright Insulin Supply Partner Amphastar Aug 06 2014 
    Shareholders To Inhale Relief As MannKind Found Its Bright Insulin Supply Partner Amphastar Aug 06 2014 

    More From Other Websites
    Afrezza Breathes Life Into MannKind Jan 27 2015
    Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger Jan 12 2015
    Mann steps down as CEO of inhaled insulin maker MannKind Corp. Jan 12 2015
    MannKind Gets Little Love From Sanofi at 'JPM15' Presentation Jan 12 2015
    MannKind Appoints Edstrom CEO Jan 12 2015
    MANNKIND CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jan 12 2015
    MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom... Jan 12 2015
    MANNKIND CORP Files SEC form 8-K, Other Events Jan 08 2015
    MannKind Earns $50 Million in Milestone Payments From Sanofi Jan 08 2015
    MannKind Corporation to Present at the J.P. Morgan 2015 Healthcare Conference Jan 07 2015
    Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens Dec 29 2014
    MannKind Sees More Insider Selling Dec 04 2014
    MannKind Corporation to Present at The 26th Annual Piper Jaffray Healthcare Conference Nov 25 2014
    MannKind's Afrezza Remains in Sanofi's Plans, RBC Says Nov 21 2014
    MANNKIND CORP Financials Nov 19 2014
    10-Q for MannKind Corp. Nov 12 2014
    MANNKIND CORP Files SEC form 10-Q, Quarterly Report Nov 10 2014
    Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership Nov 04 2014
    [$$] MannKind's Progress Seen More Gradual Nov 04 2014
    MannKind Falls on Missing Q3 Estimates Yet Cuts Loss Y/Y Nov 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial